Moderate
Suspected
Mô tả
Fluoxetine plus sumatriptan may potentiate serotonin syndrome risk, though the clinical evidence is mixed and the absolute risk is debated.
Cơ chế
Fluoxetine inhibits serotonin reuptake and is a potent CYP2D6 inhibitor which may modestly increase sumatriptan exposure; combined serotonergic activity raises theoretical serotonin syndrome risk.
Ý nghĩa lâm sàng
Post-marketing surveillance reports exist; many clinical guidelines permit the combination with monitoring, given frequent co-prescription in migraine.
Xử trí
Combination is commonly used; monitor for signs of serotonin syndrome especially at treatment initiation or dose escalation.